| Pharmaceutical Information |
| Drug Name |
Thioproperazine |
| Drug ID |
BADD_D02638 |
| Description |
Thioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihistaminic property. It is used for the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes. |
| Indications and Usage |
For the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes. |
| Marketing Status |
experimental |
| ATC Code |
N05AB08 |
| DrugBank ID |
DB01622
|
| KEGG ID |
D08585
|
| MeSH ID |
C084825
|
| PubChem ID |
9429
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
YJ050AQ56X
|
| Synonyms |
thioproperazine | thioproperazine mesylate | Majeptil |
|
| Chemical Information |
| Molecular Formula |
C22H30N4O2S2 |
| CAS Registry Number |
316-81-4 |
| SMILES |
CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
